31754-00-4Relevant academic research and scientific papers
Stimuli responsive chiral liquid crystal phases of phenylboronic acid functionalized rodlike viruses and their interaction with biologically important diols
Cao, Jun,Liu, Shuaiyu,Xiong, Jie,Chen, Yingjun,Zhang, Zhenkun
, p. 10402 - 10405 (2014)
The rodlike M13 viruses with chemically decorated phenylboronic acid moieties form pH responsive chiral nematic liquid crystal (LC) phases. Binding with biologically important diols results in LC phases with microstructures that closely correlate with the molecular structure of the diols and can be conveniently discerned by visual cues. This journal is the Partner Organisations 2014.
Gels and multilayer surface structures from boronic acid containing polymers
-
, (2008/06/13)
Boronic acid containing polymers are used to form bioinert gels and multilayer surface structures. These polymers form crosslinked hydrogels, which are highly swollen in water. The crosslinking can either be chemical or physical. Water soluble polymers containing boronic acid groups, such as phenylboronic acid (PBA), can be physically crosslinked by mixing the polymers in water with other polymers containing hydroxyls or carboxylic acids. Alternatively, surfaces can be treated by stepwise incubation with a solution of the boronic acid containing polymer, followed by incubation with a solution of a diol or carboxylic acid containing polymer. Many successive layers can be generated, increasing the thickness of the formed structure at each step. The bioinert gel or surface coating can be used for passivating the surfaces of medical implants (especially those based on transplanted tissue), or for passivating the surfaces of tissues in situ, decreasing the incidence or severity of such pathologic conditions as the formation of post-surgical adhesions, and thrombosis following angioplasty.
Phenylboronic acid complexes for bioconjugate preparation
-
, (2008/06/13)
The present invention relates to a novel class of phenylboronic acid bioconjugate complexes derived from aminosalicylic acid, and the method of making and using such bioconjugate complexes. The bioconjugate complexes are in the form of the following gener
